The identification of a gene that helps to restrict the host range of the modified vaccinia virus Ankara (MVA) could lead to the development of new and improved vaccines against diverse infectious agents, according to a study published May 30 in the open-access journal PLOS Pathogens by Bernard Moss of the National Institutes of Health, and colleagues.
* This article was originally published here
